Status:
UNKNOWN
Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study
Lead Sponsor:
Sociedad Espanola de Angiologia y Cirugia Vascular
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
There is an urgent need to understand the outcomes of COVID-19 infected patients regarding the thromboembolic venous disease. Capturing real-world data and sharing Spanish national experience will inf...
Eligibility Criteria
Inclusion
- Adults (age 18 years) considered as a case of COVID-19 disease with suspected DVT in lower and/or upper limbs: (i) A laboratory test confirming COVID-19 infection or (ii) a clinical diagnosis of COVID-19 infection (without any testing) is considered.
- \- Suspected DVT:
- Patients with clinical data of suspected DVT
- and/or patients with analytical data on suspected DVT
- and/or patients with ultrasound data of suspected DVT
Exclusion
- \-
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04361981
Start Date
April 1 2020
End Date
December 31 2020
Last Update
April 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Red de Investigacion Vascular (SEACV)
Madrid, Spain, 28004